- Anatomy Of The National Drug Code
- FDA Postpones Enforcement of DSCSA Transaction Data Exchange Until May 1
- DSCSA: Transaction Statement
- Global Traceability Data Exchange: Troubled Waters Ahead
- Will The DSCSA Cause Drug Shortages After January 1?
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- The Coming Battle Over Decommissioning At The Pharmacy
The U.S. Senate has passed H.R. 3204, the Drug Quality and Security Act (DQSA) with a voice vote, sending the important legislation to the desk of President Barack Obama. The President is expected to sign it happily. In an email to members, John M. Gray, President and CEO of the Healthcare Distribution Management Association (HDMA) stated:
“Today the U.S. Senate passed the Drug Quality and Security Act (H.R. 3204). We expect it will be quickly signed into law by the President. This is the culmination of nearly 10 years of effort by HDMA members to preempt all state laws relating to drug pedigrees and track-and-trace systems, to further enhance the security and safety of our nation’s drug supply chain. Since 2004, HDMA has spearheaded industry efforts to preempt multiple and conflicting state laws related to pedigree and the traceability of drugs. …”
See the related press release here.
I also expect President Obama to sign the bill into law. As I said in my essay earlier today (see “All Eyes On The U.S. Senate Tonight”), I will begin work on adding a banner to the top of all obsolete RxTrace essays and I will begin writing about the implications of the new prospective law. Clients of Dirk Rodgers Consulting, LLC are welcome to contact me to schedule conference calls to discuss the implications to your projects and your businesses going forward. All projects should be re-evaluated in light of this major action.
2 Responses to “U.S. Senate Passes H.R. 3204 With A Voice Vote”
RxTrace offers unique context and focus on our industry.
RxTrace is the most informative and most current source for information on tracking pharma using AIDC. Their integration of information on UDI is also rather unique. RxTrace serves the pharma stakeholders as the pharma business model evolves to include services enabled by AIDC.
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
The information provided is up-to-date and provides a pragmatic presentation and discussion of the pertinent issues as they unfold. It is an excellent and comprehensive summary.
RxTrace distills the complexities of pharmaceutical supply chain issues to simple concepts and also accurately projects issues on the horizon that industry leaders and legislators should heed.
The first website I visit on Monday mornings is RxTrace
Rx Trace is an excellent source of timely industry insight that take complex topics and makes them easier to digest and understand
I rely heavily on RxTrace to understand what is changing with the DSCSA, the latest with the FDA and the industry in general.
ROC IT Solutions uses RxTrace to help keep abreast with the industry view(s) on the DQSA legislation and how companies are dealing with meeting the mandates. The views and insights are valuable to our assessment of how our product roadmap reacts to best serve our clients.
Look forward to RxTrace News-helps me to better manage key issues
Dirk is an independent consultant and founder of RxTrace. He has contributed to many of the industry groups that have been formed over the last 10 years to investigate solutions to the problem of counterfeit and other illegitimate drugs in the legitimate supply chain. He served as co-chair of a number of key technical work groups in GS1 and GS1 US. These include the original GS1 EPCglobal Drug Pedigree Messaging work group that created the DPMS pedigree standard, the Network Centric ePedigree (NCeP) work group and the RFID Barcode Interoperability Guideline work group. Dirk holds a BS in Electrical and Computer Engineering from the University of Wisconsin-Madison.
View the Dirk Rodgers Consulting, LLC website
View Dirk's LinkedIn Profile
Follow Dirk on Twitter
Senate Bill to Curb Prescription Drug Diversion, Abuse Supported by NACDS lnkd.in/dDHSQE6
EFPIA - New Landmark in fight against counterfeit medicines with establishment of the European... lnkd.in/eeEt3dH
Kevin Wilson www.rxtrace.com/testimonial/ke…
Dirk A. Rodgers
February 27, 2015 (10:11)
Is An ASN Really The Best Way to Pass Lot-Based DSCSA Transaction Data?Marsha, Thanks for providing us with your company's real-world experience wit...
Dirk A. Rodgers
February 27, 2015 (10:02)
When Will The DSCSA Ever Require Investments In Aggregation?Sunil, Thanks for commenting. I share your concern about how the industry gr...
Marsha Flores Harris
February 26, 2015 (10:08)
Is An ASN Really The Best Way to Pass Lot-Based DSCSA Transaction Data?Dirk - Thanks for the discussion. What I've found from our customers, parti...
February 26, 2015 (8:25)
When Will The DSCSA Ever Require Investments In Aggregation?I have always wondered how aggregated hierarchical data will be tracked in th...
Dirk A. Rodgers
February 23, 2015 (4:40)
DSCSA Exception Handling: A Preview of Your Next Surprise HeadacheRandy, Thanks for your reply and your compliments. You are exactly right th...